10:23 AM EDT, 08/27/2024 (MT Newswires) -- Okyo Pharma ( OKYO ) said Tuesday it received a US patent for OK-101 to treat symptoms of dry eye disease.
The patent, issued Aug. 6, covers the use of OK-101 to treat irritated, burning eyes and blurred vision in patients with dry eye disease, according to the company.
Price: 0.94, Change: -0.01, Percent Change: -1.34